Skip to main content
OpenTrials

Clinical trial condition

DLBCL - Diffuse Large B Cell Lymphoma

Explore clinical trials studying DLBCL - Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

41 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

DLBCL - Diffuse Large B Cell Lymphoma trial results

Active, Not Recruiting

An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme

NCT06734078

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations
  • IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
  • Casa Sollievo della Sofferenza - Reparto di Oncoematologia San Giovanni Rotondo, Foggia, Italy
  • Azienda Ospedaliera Universitaria- Policlinico di Bari Bari, Italy
  • Ospedale Oncologico Armando Businco Cagliari, Italy
View Trial Details

Related conditions